- Home
- KPTI vs SGC Comparison
KPTI vs SGC Comparison
Compare KPTI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | SGC |
|---|---|---|
| Founded | 2008 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 168.2M |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | KPTI | SGC |
|---|---|---|
| Price | $8.27 | $10.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $15.40 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 803.4K | 30.4K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | ★ 5.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $146,067,000.00 | ★ $566,184,000.00 |
| Revenue This Year | N/A | $0.73 |
| Revenue Next Year | $46.62 | $3.38 |
| P/E Ratio | ★ N/A | $22.33 |
| Revenue Growth | ★ 0.57 | 0.09 |
| 52 Week Low | $3.51 | $8.30 |
| 52 Week High | $10.99 | $14.46 |
Technical Indicators
Market Signals| Indicator | KPTI | SGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 49.14 |
| Support Level | $5.60 | $9.72 |
| Resistance Level | $8.95 | $10.48 |
| Average True Range (ATR) | 0.70 | 0.43 |
| MACD | -0.21 | 0.00 |
| Stochastic Oscillator | 0.36 | 36.53 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.